Back to UBS Group AG UBS Group AG

INDPINDP
4 quarters

Position history for UBS Group AGUBS Group AG's holdings in INDAPTUS THERAPEUTICS INC

Yes. Ubs holds 478 shares of INDP (Indaptus Therapeutics), worth $1,434, as of its Q2 2026 13F filing. It opened the position in Q2 2026.

Current Value

$1,434

Current Shares

478

Total Value Change

-$7

Total Shares Change

-24

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
478
-
$1,4340.0%$3.00
17
2026-Q1
Exited
0
-100.0%
$00.0%$1.88
0
2025-Q4
Increased
29,002
+5677.3%
$84,3960.0%$2.72
24
2025-Q3
New
502
-
$1,4410.0%$2.99
17

Other major holders of INDP: HRT FINANCIAL LP, GEODE CAPITAL MANAGEMENT, LLC, JANE STREET GROUP, LLC, VANGUARD CAPITAL MANAGEMENT LLC, CITADEL ADVISORS LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used